Evan Kearns

Evan Kearns has an estimated net worth of $10.9 Million. This is based on reported shares across multiple companies, which include Cogent Biosciences, Inc., and AGENUS INC.

2025 was Evan Kearns's most active year for acquiring shares with 4 total transactions. Evan Kearns's most active month to acquire stocks was the month of November. 2025 was Evan Kearns's most active year for disposing of shares, totalling 2 transactions. Evan Kearns's most active month to dispose stocks was the month of November. 2022 saw Evan Kearns paying a total of $999,762.20 for 202,250 shares, this is the most they've acquired in one year. In 2025 Evan Kearns cashed out on 190,602 shares for a total of $7,470,498.90, their largest year based on trade value.